|
Genes Directly Associated with Breast Cancer: CDKN1A (p21Wap1/Cip1), CLDN7 (claudin-7), CLU (clusterin), ERBB2 (Her-2), FGF1, FLRT1 (fibronectin), GABRP (GABAa), GNAS, ID2, ITGA6, ITGB4 (ß4 integrin), KLF5 (GC Box BP), KRT19 (Keratin 19), MT3 (metallothionectin-III), MUC1 (mucin), PTGS2 (COX-2), RAC2 (p21Rac2), SCGB1D2 (lipophilin B), SCGB2A1 (mammaglobin 2), SPRR1B (Spr1), THBS1, THBS2, TNFAIP2 (B94).
Genes Associated with the Estrogen Receptor Signaling Pathway: AR, C3 (Complement component 3), CCND1, CTSD (cathepsin D), ESR1, ESR2, GATA3, HSPB1 (HSP28), KRT18, KRT19 (Keratin 19), PGR, SERPINA3 (a1-antichmotrypsin), SLC7A5, STC2, TFF1 (pS2).
Genes Associated with Breast Cancer Prognosis: BAD, BAG1, BCL2, CCNA1, CCNA2, CCND1, CCNE1, CDH1 (E-cadherin), CDKN1B (p27Kip1), CDKN2A (p16INK4a), COL6A1, CTNNB1 (b-catenin), CTSB (cathepsin B), EGFR, ERBB2 (Her-2), ESR1, ESR2, FAS (TNFRSF6), FASLG (TNFSF6), FOSL1 (FRA-1), GATA3, GSN (Gelsolin), IGFBP2, IL2RA, IL6, IL6R, IL6ST (glycoprotein 130), ITGA6 (a6 integrin), JUN, KLK5, KRT19, MAP2K7, MKI67 (Ki-67), NGFB (NGF), NGFR, NME1 (NM23A), PGR, PLAU (uPA), PTEN, SERPINB5 (maspin), SERPINE1 (PAI-1), TGFA, THBS1 (thrombospondin-1), TIE1(Tie-1), TOP2A (topoisomerase Iia), TP53, VEGFA.
Genes Associated with the Response to Chemotherapy: BCL2BCL2, BCL2L2, CD44, CTSD (cathepsin D), CYP19A1, DLC1, ESR1, ESR2, HMGB1, KIT, NFYB, PAPPA, PGR, RPL27, VEGFA.
|